Maglathlin RL - Search Results

1

Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.

Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O'Kane CJ, Schreiber SL, Rubinsztein DC. Sarkar S, et al. Among authors: maglathlin rl. Nat Chem Biol. 2007 Jun;3(6):331-8. doi: 10.1038/nchembio883. Epub 2007 May 7. Nat Chem Biol. 2007. PMID: 17486044 Free PMC article.

2

Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis.

Chou DH, Holson EB, Wagner FF, Tang AJ, Maglathlin RL, Lewis TA, Schreiber SL, Wagner BK. Chou DH, et al. Among authors: maglathlin rl. Chem Biol. 2012 Jun 22;19(6):669-73. doi: 10.1016/j.chembiol.2012.05.010. Chem Biol. 2012. PMID: 22726680 Free PMC article.

3

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.

Du J, Bernasconi P, Clauser KR, Mani DR, Finn SP, Beroukhim R, Burns M, Julian B, Peng XP, Hieronymus H, Maglathlin RL, Lewis TA, Liau LM, Nghiemphu P, Mellinghoff IK, Louis DN, Loda M, Carr SA, Kung AL, Golub TR. Du J, et al. Among authors: maglathlin rl. Nat Biotechnol. 2009 Jan;27(1):77-83. doi: 10.1038/nbt.1513. Epub 2008 Dec 21. Nat Biotechnol. 2009. PMID: 19098899 Free PMC article.

4

Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.

Fass DM, Shah R, Ghosh B, Hennig K, Norton S, Zhao WN, Reis SA, Klein PS, Mazitschek R, Maglathlin RL, Lewis TA, Haggarty SJ. Fass DM, et al. Among authors: maglathlin rl. ACS Med Chem Lett. 2010 Oct 8;2(1):39-42. doi: 10.1021/ml1001954. ACS Med Chem Lett. 2010. PMID: 21874153 Free PMC article.

5

A powerful combinatorial screen to identify high-affinity terbium(III)-binding peptides.

Nitz M, Franz KJ, Maglathlin RL, Imperiali B. Nitz M, et al. Among authors: maglathlin rl. Chembiochem. 2003 Apr 4;4(4):272-6. doi: 10.1002/cbic.200390047. Chembiochem. 2003. PMID: 12672106

6

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles.

Serafimova IM, Pufall MA, Krishnan S, Duda K, Cohen MS, Maglathlin RL, McFarland JM, Miller RM, Frödin M, Taunton J. Serafimova IM, et al. Among authors: maglathlin rl. Nat Chem Biol. 2012 Apr 1;8(5):471-6. doi: 10.1038/nchembio.925. Nat Chem Biol. 2012. PMID: 22466421 Free PMC article.

7

Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.

Ruiz-Saenz A, Sandhu M, Carrasco Y, Maglathlin RL, Taunton J, Moasser MM. Ruiz-Saenz A, et al. Among authors: maglathlin rl. Oncogene. 2015 Oct 8;34(41):5288-94. doi: 10.1038/onc.2014.455. Epub 2015 Jan 26. Oncogene. 2015. PMID: 25619841 Free PMC article.

8

Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.

Juncosa JI Jr, Hansen M, Bonner LA, Cueva JP, Maglathlin R, McCorvy JD, Marona-Lewicka D, Lill MA, Nichols DE. Juncosa JI Jr, et al. ACS Chem Neurosci. 2013 Jan 16;4(1):96-109. doi: 10.1021/cn3000668. Epub 2012 Jul 17. ACS Chem Neurosci. 2013. PMID: 23336049 Free PMC article.

9

A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.

McCorvy JD, Harland AA, Maglathlin R, Nichols DE. McCorvy JD, et al. Neurosci Lett. 2011 Nov 7;505(1):10-3. doi: 10.1016/j.neulet.2011.07.036. Epub 2011 Jul 30. Neurosci Lett. 2011. PMID: 21827831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page